Article

The Spokesman-Review on 2019-04-19 22:57

FDA OKs 1st generic nasal spray of overdose reversal drug - Fri, 19 Apr 2019 PST

U.S. regulators have approved the first generic nasal spray version of Narcan, a drug that reverses opioid overdoses. The Food and Drug Administration ...

Related news

FDA OKs 1st generic nasal spray of overdose reversal drug Seattle Times
Israel
Teva gets FDA approval for 1st generic nasal spray of overdose reversal drug timesofisrael.com
New York , Israel
MFDA approves first generic naloxone nasal spray to treat opioid overdose marketwatch.com
Israel
Maui police to carry nasal spray for opioid overdose victims bradenton.com
Hawaii
Teva Gets Approval to Sell Generic Nasal Spray for Opioid Overdoses wsj.com
NFDA approves first over-the-counter nasal spray for opioid OD reversal nypost.com
California is joining with a New Jersey company to buy a generic opioid overdose reversal drug Seattle Times
New Jersey , California
BUK prof’s live-saving anti-overdose nasal spray on FDA fast track bizlex.com
Lexington , Phase 2
Accused of complicity in opioid crisis, Teva launches nasal spray to treat overdose timesofisrael.com
Louisiana , Israel
MFDA approves Adapt Pharma's 2mg version of opioid overdose treatment Narcan Nasal Spray marketwatch.com
N.J. gave away 32K doses of naloxone in 1 day this week. The nasal spray is an overdose antidote.nj.com
New Jersey , Americas , Baltimore
Senior Brazil delegation in Israel for talks on Israeli anti-COVID nasal spray timesofisrael.com
Southern States , Phase 1 , Jerusalem , Tel Aviv , Washington
Study: Israeli anti-COVID nasal spray reduced infection risk at mass gathering timesofisrael.com
Europe , Kahana , Tel Aviv , Jerusalem , Bnei Brak